Cite
HARVARD Citation
Need, E. et al. (2015). The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype. BMC cancer. 15 (1), pp. 1-17. [Online].